Research Output per year
Personal profile
Research interests
Dr. Timothy Craig has been a clinical researcher for more than 23 years and has participated in NHLBI asthma research consortiums, including ACRN and AsthmaNet. He is a leader in the field of allergy and immunology and has written guidelines for international management of urticaria, hereditary angioedema and rhinitis. He has more than 300 publications and around 400 invited lectures.
His clinical research and clinical care focuses include asthma, COPD, alpha-1-antitrypsin deficiency, urticaria, hereditary angioedema, immunodeficiency, vaccine response and other respiratory, allergic and immunologic diseases. Dr. Craig directs the Penn State Alpha-1 Deficiency Center; the Allergy, Asthma and Immunology Fellowship; the Respiratory Allergy and Immunology Clinical Research Center; and the Section of Allergy, Asthma and Immunology in the Division of Pulmonary, Allergy and Critical Care Medicine.
Dr. Craig works with collaborators in Vietnam, Cornell University and elsewhere in Penn State to study respiratory and allergic diseases. His collaborations with basic researchers in asthma include a mouse model to study how asthma affects anxiety and a mouse model to assess microbiome influence on asthma.
Teaching and educational interests
Dr. Timothy Craig's teaching interest includes the mentoring of medical students, residents and fellows. He is a Penn State College of Medicine Distinguished Educator and recently established a site in Vietnam (Lam Dong Medical College in Dalat, Vietnam) to train Penn State medical students in global health. He mentors and hosts many international students.
Education/Academic qualification
Internal Medicine, Residency, Naval Medical Center San Diego
DO, New York College Osteopathic Medicine
Allergy and Immunology, Fellowship, Walter Reed Army Medical Center
External positions
Board member, American Association of Allergy, Asthma and Immunology
Board member, Mid-Atlantic States, American Lung Association
Medical Advisory Board member, US Hereditary Angioedema Association
Fingerprint Dive into the research topics where Timothy Craig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
The Role of C1-Esterase Inhibitors in the Management of Vasogenic Edema in Glioblastoma
Naro, G. R., Noverati, N. & Craig, T., Jan 1 2020, In : Case Reports in Medicine. 2020, 7981609.Research output: Contribution to journal › Article
Open Access
A review of kallikrein inhibitor lanadelumab in hereditary angioedema
Hwang, G., Johri, A., Ng, S. & Craig, T., Jan 1 2019, In : Immunotherapy. 11, 11, p. 937-943 7 p.Research output: Contribution to journal › Article
3
Scopus
citations
Burden of Asthma and Role of 2.5 µg Tiotropium Respimat® as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials
Mansfield, L., Duong-Quy, S. & Craig, T., Oct 1 2019, In : Advances in Therapy. 36, 10, p. 2587-2599 13 p.Research output: Contribution to journal › Review article
Open Access
Clinical profile and quality of life of Puerto Ricans with hereditary angioedema
Arce-Ayala, Y. M., Diaz-Algorri, Y., Craig, T. & Ramos-Romey, C., Jan 1 2019, In : Allergy and Asthma Proceedings. 40, 2, p. 103-110 8 p.Research output: Contribution to journal › Article
1
Scopus
citations
Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention
Zhang, C., Van, D. N., Hieu, C. & Craig, T., Nov 2019, In : Annals of Allergy, Asthma and Immunology. 123, 5, p. 483-487 5 p.Research output: Contribution to journal › Article
2
Scopus
citations